- Home
- MNPR vs BYON Comparison
MNPR vs BYON Comparison
Compare MNPR & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- BYON
- Stock Information
- Founded
- MNPR 2014
- BYON 1997
- Country
- MNPR United States
- BYON United States
- Employees
- MNPR N/A
- BYON N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- BYON Catalog/Specialty Distribution
- Sector
- MNPR Health Care
- BYON Consumer Discretionary
- Exchange
- MNPR Nasdaq
- BYON Nasdaq
- Market Cap
- MNPR 244.1M
- BYON 235.5M
- IPO Year
- MNPR 2019
- BYON N/A
- Fundamental
- Price
- MNPR $40.33
- BYON $5.32
- Analyst Decision
- MNPR Strong Buy
- BYON Hold
- Analyst Count
- MNPR 5
- BYON 9
- Target Price
- MNPR $49.60
- BYON $10.93
- AVG Volume (30 Days)
- MNPR 30.6K
- BYON 3.1M
- Earning Date
- MNPR 05-08-2025
- BYON 05-05-2025
- Dividend Yield
- MNPR N/A
- BYON N/A
- EPS Growth
- MNPR N/A
- BYON N/A
- EPS
- MNPR N/A
- BYON N/A
- Revenue
- MNPR N/A
- BYON $1,394,964,000.00
- Revenue This Year
- MNPR $34.06
- BYON N/A
- Revenue Next Year
- MNPR N/A
- BYON $9.91
- P/E Ratio
- MNPR N/A
- BYON N/A
- Revenue Growth
- MNPR N/A
- BYON N/A
- 52 Week Low
- MNPR $1.72
- BYON $4.45
- 52 Week High
- MNPR $54.30
- BYON $36.07
- Technical
- Relative Strength Index (RSI)
- MNPR 56.65
- BYON 43.37
- Support Level
- MNPR $36.80
- BYON $4.66
- Resistance Level
- MNPR $43.00
- BYON $5.82
- Average True Range (ATR)
- MNPR 5.32
- BYON 0.44
- MACD
- MNPR 0.94
- BYON 0.08
- Stochastic Oscillator
- MNPR 63.41
- BYON 56.47
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About BYON Beyond Inc.
Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.